| Craig Adams, MD | |
|
4005 Orchard Dr, Midland, MI 48670-0001 | |
| (989) 839-3100 | |
| (989) 839-1393 |
| Full Name | Craig Adams |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 36 Years |
| Location | 4005 Orchard Dr, Midland, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982647384 | NPI | - | NPPES |
| 4305057 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 4301052777 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Midmichigan Medical Center-west Branch | West branch, MI | Hospital |
| Midmichigan Medical Center-clare | Clare, MI | Hospital |
| Midmichigan Medical Center-gratiot | Alma, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mymichigan Medical Center Alma | 3375451404 | 82 |
| Mymichigan Medical Center Clare | 7012829773 | 97 |
| Mymichigan Medical Center West Branch | 7214251081 | 49 |
News Archive
The national Tourette Syndrome Association and Psyadon Pharmaceuticals Inc. are pleased to announce their collaboration on a clinical trial to determine the potential efficacy of a novel drug, ecopipam, for managing the symptoms of the neurological disorder Tourette Syndrome.
For patients with advanced lung cancer whose tumors carry EGFR activating mutations, first-line treatment with erlotinib nearly tripled progression-free survival compared to a standard chemotherapy combination, show results from the first prospective Phase-III study to report findings in this setting.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today provided an update on the status of its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
Case Western Reserve University has been approved for a research award from the Patient-Centered Outcomes Research Institute (PCORI) to study ways that applying patients' strengths can help enhance their health care and well-being. The project is part of a portfolio of patient-centered comparative clinical effectiveness research that addresses PCORI's National Priorities for Research and Research Agenda.
Evidence of tiny particles of carbon, typically created by burning fossil fuels, has been found in placentas for the first time, in new research presented today at the European Respiratory Society International Congress.
› Verified 4 days ago
| Entity Name | Mymichigan Medical Center Alma |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265596126 PECOS PAC ID: 3375451404 Enrollment ID: O20040202000975 |
News Archive
The national Tourette Syndrome Association and Psyadon Pharmaceuticals Inc. are pleased to announce their collaboration on a clinical trial to determine the potential efficacy of a novel drug, ecopipam, for managing the symptoms of the neurological disorder Tourette Syndrome.
For patients with advanced lung cancer whose tumors carry EGFR activating mutations, first-line treatment with erlotinib nearly tripled progression-free survival compared to a standard chemotherapy combination, show results from the first prospective Phase-III study to report findings in this setting.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today provided an update on the status of its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
Case Western Reserve University has been approved for a research award from the Patient-Centered Outcomes Research Institute (PCORI) to study ways that applying patients' strengths can help enhance their health care and well-being. The project is part of a portfolio of patient-centered comparative clinical effectiveness research that addresses PCORI's National Priorities for Research and Research Agenda.
Evidence of tiny particles of carbon, typically created by burning fossil fuels, has been found in placentas for the first time, in new research presented today at the European Respiratory Society International Congress.
› Verified 4 days ago
| Entity Name | Epmg Of Michigan Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386688992 PECOS PAC ID: 4789596339 Enrollment ID: O20040211000686 |
News Archive
The national Tourette Syndrome Association and Psyadon Pharmaceuticals Inc. are pleased to announce their collaboration on a clinical trial to determine the potential efficacy of a novel drug, ecopipam, for managing the symptoms of the neurological disorder Tourette Syndrome.
For patients with advanced lung cancer whose tumors carry EGFR activating mutations, first-line treatment with erlotinib nearly tripled progression-free survival compared to a standard chemotherapy combination, show results from the first prospective Phase-III study to report findings in this setting.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today provided an update on the status of its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
Case Western Reserve University has been approved for a research award from the Patient-Centered Outcomes Research Institute (PCORI) to study ways that applying patients' strengths can help enhance their health care and well-being. The project is part of a portfolio of patient-centered comparative clinical effectiveness research that addresses PCORI's National Priorities for Research and Research Agenda.
Evidence of tiny particles of carbon, typically created by burning fossil fuels, has been found in placentas for the first time, in new research presented today at the European Respiratory Society International Congress.
› Verified 4 days ago
| Entity Name | Mymichigan Medical Center Midland |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205889490 PECOS PAC ID: 2264323633 Enrollment ID: O20040324000137 |
News Archive
The national Tourette Syndrome Association and Psyadon Pharmaceuticals Inc. are pleased to announce their collaboration on a clinical trial to determine the potential efficacy of a novel drug, ecopipam, for managing the symptoms of the neurological disorder Tourette Syndrome.
For patients with advanced lung cancer whose tumors carry EGFR activating mutations, first-line treatment with erlotinib nearly tripled progression-free survival compared to a standard chemotherapy combination, show results from the first prospective Phase-III study to report findings in this setting.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today provided an update on the status of its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
Case Western Reserve University has been approved for a research award from the Patient-Centered Outcomes Research Institute (PCORI) to study ways that applying patients' strengths can help enhance their health care and well-being. The project is part of a portfolio of patient-centered comparative clinical effectiveness research that addresses PCORI's National Priorities for Research and Research Agenda.
Evidence of tiny particles of carbon, typically created by burning fossil fuels, has been found in placentas for the first time, in new research presented today at the European Respiratory Society International Congress.
› Verified 4 days ago
| Entity Name | Mymichigan Medical Center Alpena |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508332792 PECOS PAC ID: 8527969922 Enrollment ID: O20040415000495 |
News Archive
The national Tourette Syndrome Association and Psyadon Pharmaceuticals Inc. are pleased to announce their collaboration on a clinical trial to determine the potential efficacy of a novel drug, ecopipam, for managing the symptoms of the neurological disorder Tourette Syndrome.
For patients with advanced lung cancer whose tumors carry EGFR activating mutations, first-line treatment with erlotinib nearly tripled progression-free survival compared to a standard chemotherapy combination, show results from the first prospective Phase-III study to report findings in this setting.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today provided an update on the status of its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
Case Western Reserve University has been approved for a research award from the Patient-Centered Outcomes Research Institute (PCORI) to study ways that applying patients' strengths can help enhance their health care and well-being. The project is part of a portfolio of patient-centered comparative clinical effectiveness research that addresses PCORI's National Priorities for Research and Research Agenda.
Evidence of tiny particles of carbon, typically created by burning fossil fuels, has been found in placentas for the first time, in new research presented today at the European Respiratory Society International Congress.
› Verified 4 days ago
| Entity Name | Harbor Beach Community Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619059458 PECOS PAC ID: 7214903483 Enrollment ID: O20040908001458 |
News Archive
The national Tourette Syndrome Association and Psyadon Pharmaceuticals Inc. are pleased to announce their collaboration on a clinical trial to determine the potential efficacy of a novel drug, ecopipam, for managing the symptoms of the neurological disorder Tourette Syndrome.
For patients with advanced lung cancer whose tumors carry EGFR activating mutations, first-line treatment with erlotinib nearly tripled progression-free survival compared to a standard chemotherapy combination, show results from the first prospective Phase-III study to report findings in this setting.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today provided an update on the status of its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
Case Western Reserve University has been approved for a research award from the Patient-Centered Outcomes Research Institute (PCORI) to study ways that applying patients' strengths can help enhance their health care and well-being. The project is part of a portfolio of patient-centered comparative clinical effectiveness research that addresses PCORI's National Priorities for Research and Research Agenda.
Evidence of tiny particles of carbon, typically created by burning fossil fuels, has been found in placentas for the first time, in new research presented today at the European Respiratory Society International Congress.
› Verified 4 days ago
| Entity Name | Mymichigan Medical Center Clare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134394026 PECOS PAC ID: 7012829773 Enrollment ID: O20080721000628 |
News Archive
The national Tourette Syndrome Association and Psyadon Pharmaceuticals Inc. are pleased to announce their collaboration on a clinical trial to determine the potential efficacy of a novel drug, ecopipam, for managing the symptoms of the neurological disorder Tourette Syndrome.
For patients with advanced lung cancer whose tumors carry EGFR activating mutations, first-line treatment with erlotinib nearly tripled progression-free survival compared to a standard chemotherapy combination, show results from the first prospective Phase-III study to report findings in this setting.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today provided an update on the status of its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
Case Western Reserve University has been approved for a research award from the Patient-Centered Outcomes Research Institute (PCORI) to study ways that applying patients' strengths can help enhance their health care and well-being. The project is part of a portfolio of patient-centered comparative clinical effectiveness research that addresses PCORI's National Priorities for Research and Research Agenda.
Evidence of tiny particles of carbon, typically created by burning fossil fuels, has been found in placentas for the first time, in new research presented today at the European Respiratory Society International Congress.
› Verified 4 days ago
| Entity Name | Mymichigan Medical Center West Branch |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538566765 PECOS PAC ID: 7214251081 Enrollment ID: O20160714002424 |
News Archive
The national Tourette Syndrome Association and Psyadon Pharmaceuticals Inc. are pleased to announce their collaboration on a clinical trial to determine the potential efficacy of a novel drug, ecopipam, for managing the symptoms of the neurological disorder Tourette Syndrome.
For patients with advanced lung cancer whose tumors carry EGFR activating mutations, first-line treatment with erlotinib nearly tripled progression-free survival compared to a standard chemotherapy combination, show results from the first prospective Phase-III study to report findings in this setting.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today provided an update on the status of its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
Case Western Reserve University has been approved for a research award from the Patient-Centered Outcomes Research Institute (PCORI) to study ways that applying patients' strengths can help enhance their health care and well-being. The project is part of a portfolio of patient-centered comparative clinical effectiveness research that addresses PCORI's National Priorities for Research and Research Agenda.
Evidence of tiny particles of carbon, typically created by burning fossil fuels, has been found in placentas for the first time, in new research presented today at the European Respiratory Society International Congress.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Craig Adams, MD 2000 Dilloway Dr, Midland, MI 48640-6770 Ph: (989) 631-2889 | Craig Adams, MD 4005 Orchard Dr, Midland, MI 48670-0001 Ph: (989) 839-3100 |
News Archive
The national Tourette Syndrome Association and Psyadon Pharmaceuticals Inc. are pleased to announce their collaboration on a clinical trial to determine the potential efficacy of a novel drug, ecopipam, for managing the symptoms of the neurological disorder Tourette Syndrome.
For patients with advanced lung cancer whose tumors carry EGFR activating mutations, first-line treatment with erlotinib nearly tripled progression-free survival compared to a standard chemotherapy combination, show results from the first prospective Phase-III study to report findings in this setting.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today provided an update on the status of its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
Case Western Reserve University has been approved for a research award from the Patient-Centered Outcomes Research Institute (PCORI) to study ways that applying patients' strengths can help enhance their health care and well-being. The project is part of a portfolio of patient-centered comparative clinical effectiveness research that addresses PCORI's National Priorities for Research and Research Agenda.
Evidence of tiny particles of carbon, typically created by burning fossil fuels, has been found in placentas for the first time, in new research presented today at the European Respiratory Society International Congress.
› Verified 4 days ago
Carleton D Winegar, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4005 Orchard Dr, Midland, MI 48670 Phone: 989-839-3100 Fax: 989-839-1393 | |
Dr. Belinda Hoover Brewster, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2677 E Blackhurst Rd, Midland, MI 48642 Phone: 989-837-6632 Fax: 989-837-6632 | |
Dr. Zachary J Sawaya, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4000 Wellness Dr, Midland, MI 48670 Phone: 989-839-3000 Fax: 989-839-1393 | |
Erich Christian Kickland, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4005 Orchard Dr, Midland, MI 48670 Phone: 989-839-3100 | |
Jesse G Walker, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4005 Orchard Dr, Midland, MI 48670 Phone: 989-839-3100 Fax: 989-839-1393 | |
Jeffrey S Newman, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4005 Orchard Dr, Midland, MI 48670 Phone: 989-839-3100 Fax: 989-839-1393 | |
Dr. David Eric Newcomb Ii, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: Emergency Department Mid-michigan Regional Med Ctr, 4005 Orchard Drive, Midland, MI 48670 Phone: 989-839-3230 |